Sign In
Buy PFE
$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
Ranking The 10 Largest Biotechs By Pipeline
12:34pm, Wednesday, 11'th Jan 2023
The pipeline is the heart of all drug discovery companies, leading to all growth in the future. As such, understanding the relative strength of a pipeline by comparing to peers can lead to investment
China takes first steps to punish countries that imposed testing mandates for Chinese travelers
11:52am, Wednesday, 11'th Jan 2023 MarketWatch
China suspended visas for South Koreans on Tuesday in a tit-for-tat response to that country's COVID testing requirement for Chinese tourists.
Should You Invest in the Health Care Select Sector SPDR ETF (XLV)?
11:20am, Wednesday, 11'th Jan 2023 Zacks Investment Research
Sector ETF report for XLV
3 Supercharged Dividend Stocks to Buy If There's a Stock Market Sell-Off
07:50am, Wednesday, 11'th Jan 2023
These three healthcare stocks all deliver dependable dividends, with yields of 3% or more.
Pfizer (PFE) Stock Sinks As Market Gains: What You Should Know
10:45pm, Tuesday, 10'th Jan 2023 Zacks Investment Research
Pfizer (PFE) closed at $47.62 in the latest trading session, marking a -1.59% move from the prior day.
HPE appoints former Pfizer CFO D'Amelio to board
04:26pm, Tuesday, 10'th Jan 2023
Hewlett Packard Enterprise Co. HPE, +0.59% on Tuesday appointed Frank D'Amelio, former chief financial officer of Pfizer Inc. PFE, -1.59% , to HPE's board of directors. D'Amelio has more than 40 years
Novavax (NVAX) Names John Jacobs as New CEO, Shares Rise
04:24pm, Tuesday, 10'th Jan 2023 Zacks Investment Research
Novavax (NVAX) appoints John C. Jacobs as its new president and chief executive officer, effective Jan 23, 2023.
3 Passive Income Stocks That Are Screaming Buys in January
02:45pm, Tuesday, 10'th Jan 2023 The Motley Fool
All three could make investors a little bit richer every quarter.
Pfizer Rebuts Generic Version Of COVID-19 Oral Treatment In China, Says It's Not A Poor Country
01:08pm, Tuesday, 10'th Jan 2023 Benzinga
Pfizer Inc (NYSE: PFE) CEO Albert Bourla rebuffed reports saying the company is in talks with Chinese authorities to license a generic version of its Covid-19 treatment Paxlovid.
Bourla speaking at
Could This Drug News Be a Catalyst for This Big Pharma Stock?
01:00pm, Tuesday, 10'th Jan 2023 The Motley Fool
Pfizer's immunology drug candidate could be approved to treat a type of inflammatory bowel disease.
Dividend Income Update: December 2022
05:30am, Tuesday, 10'th Jan 2023 Seeking Alpha
Dividend investing can work over time and anyone can create an ever-growing passive income stream. Click here for a look back at my Dec. 2022 dividend income.
Pfizer in talks with China over pricing of Covid pill
03:31am, Tuesday, 10'th Jan 2023
Pfizer Inc (NYSE:PFE) said it is talking to China about a potential price cut to provide its branded antiviral Covid pill, of which it has increasing shipments into the millions in the past two weeks.
Dividend Income Update: December 2022
12:30am, Tuesday, 10'th Jan 2023
Dividend investing can work over time and anyone can create an ever growing passive income stream. My year over year progress is moving at a nice clip.
Ranking The Top 10 Pharmaceuticals By Pipeline
11:44pm, Monday, 09'th Jan 2023
The pipeline is the heart of a drug discovery company. As such, analyzing the health of a pipeline can lead to suggestions about future performance.
Pfizer, Inc. (PFE) JPMorgan Healthcare Conference Call Transcript
11:34pm, Monday, 09'th Jan 2023
Pfizer, Inc. (NYSE:PFE ) JPMorgan Healthcare Conference January 9, 2023 6:00 PM ET Company Participants Albert Bourla - Chairman & CEO Conference Call Participants Christopher Schott - JPMorgan Chase
